Comments
Xoma's drug combo lowers high blood pressure in late-stage study
21.11.2012. | (Reuters) - Xoma Corp said its experimental combination of two drugs met the main goal of lowering hypertension better than a treatment based on either of the drugs alone in a late-stage study, sending the biotechnology company's shares up 6 percent....
